EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The CONUT score is associated with the pathologic grade in non-small cell lung cancer

Ken Onodera, Hirotsugu Notsuda, Tatsuaki Watanabe, Yui Watanabe, Takaya Suzuki, Takashi Hirama, Hisashi Oishi, Hiromichi Niikawa, Masafumi Noda, Yoshinori Okada

Surgery Today · 2024

DOI: 10.1007/s00595-024-02860-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgery Today, 2024. Verfasst von Ken Onodera und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryomachi 4-1, Aoba-ku, Sendai, Miyagi, 980-8575, Ja…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Recurrence, Local, Neoplasm Staging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Nutritional scores have been reported to be useful prognostic factors for various cancers. This study evaluated the usefulness of the preoperative controlling nutritional status (CONUT) score as a predictor of recurrence of non-small cell lung cancer (NSCLC).

Methods

The present study included 422 patients with stage I–IIIA NSCLC who underwent complete resection at Tohoku University Hospital between January 2010 and December 2016. The patients were divided into the low-CONUT and high-CONUT groups based on their CONUT scores. Overall survival (OS), recurrence-free survival (RFS), and cumulative recurrence rates in the low- and high-CONUT groups were evaluated retrospectively.

Results

One hundred forty-seven patients (34.8%) were assigned to the high-CONUT group. The high-CONUT group had a significantly worse performance status, pleural invasion, vascular invasion, and lung metastasis. In the whole cohort, the low-CONUT group showed better overall survival, recurrence-free survival, and a low cumulative recurrence rate in comparison to the high-CONUT group. There was no significant difference in prognosis or recurrence between the low- and high-CONUT groups after propensity score matching.

Conclusion

Patients with a high CONUT score may be at high risk of recurrence because of the high frequency of pleural invasion, vascular invasion, and lung metastasis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoplasm Recurrence, LocalNeoplasm StagingNeoplasm GradingHumansMaleFemaleAgedPrognosisMiddle AgedRetrospective StudiesSurvival RateNeoplasm InvasivenessNutritional StatusPreoperative PeriodRiskAged, 80 and over

Stichwörter der Autor:innen

CONUTEarly stageLung cancerNSCLCNutritional status

Autor:innen und Institutionen

  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryomachi 4-1, Aoba-ku, Sendai, Miyagi, 980-8575, Japan. ken.onodera.c3@tohoku.ac.jp.
  • Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Seiryomachi 4-1, Aoba-ku, Sendai, Miyagi, 980-8575, Japan.

Zitieren

APA

Onodera, K., Notsuda, H., Watanabe, T., Watanabe, Y., Suzuki, T., Hirama, T., Oishi, H., Niikawa, H., Noda, M., & Okada, Y. (2024). The CONUT score is associated with the pathologic grade in non-small cell lung cancer. Surgery Today. https://doi.org/10.1007/s00595-024-02860-8

Vancouver

Onodera K, Notsuda H, Watanabe T, Watanabe Y, Suzuki T, Hirama T, et al. The CONUT score is associated with the pathologic grade in non-small cell lung cancer. Surgery Today. 2024. doi:10.1007/s00595-024-02860-8

BibTeX
@article{Onodera2024,
  author = {Onodera, Ken and Notsuda, Hirotsugu and Watanabe, Tatsuaki and Watanabe, Yui and Suzuki, Takaya and Hirama, Takashi and Oishi, Hisashi and Niikawa, Hiromichi and Noda, Masafumi and Okada, Yoshinori},
  title = {The CONUT score is associated with the pathologic grade in non-small cell lung cancer},
  journal = {Surgery Today},
  year = {2024},
  doi = {10.1007/s00595-024-02860-8}
}
Kostenlos starten →